Detalhe da pesquisa
1.
Population pharmacokinetics and exposure-response relationship of trastuzumab and bevacizumab in early-stage breast cancer.
Eur J Clin Pharmacol
; 77(12): 1861-1873, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245336
2.
Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database.
Breast Cancer Res Treat
; 178(3): 505-512, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31486993
3.
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial.
Ann Oncol
; 29(8): 1777-1783, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29893791
4.
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer.
Ann Oncol
; 29(1): 162-169, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29077781
5.
Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer.
Ann Oncol
; 28(9): 2233-2240, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28911063
6.
Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study.
Ann Oncol
; 28(8): 1996-2001, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28459943
7.
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab.
Ann Oncol
; 28(1): 103-109, 2017 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28177480
8.
Prediction of long-term cumulative incidences based on short-term parametric model for competing risks: application in early breast cancer.
Breast Cancer Res Treat
; 156(3): 577-585, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27075918
9.
Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models.
Br J Cancer
; 112(5): 912-7, 2015 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25590666
10.
Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy.
Br J Cancer
; 113(1): 30-6, 2015 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26079300
11.
Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma.
Br J Cancer
; 113(7): 996-1002, 2015 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26379080
12.
Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.
Ann Oncol
; 26(1): 89-94, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25355723
13.
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer.
Ann Oncol
; 26(8): 1704-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25953157
14.
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer.
Ann Oncol
; 26(8): 1692-7, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25943350
15.
Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma.
Br J Cancer
; 110(9): 2195-200, 2014 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24714751
16.
Trastuzumab duration effects within patient prognostic subgroups in the PHARE trial.
Ann Oncol
; 25(8): 1563-70, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24827132
17.
Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study.
Breast Cancer Res Treat
; 148(2): 345-53, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25318926
18.
Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab.
Br J Cancer
; 108(9): 1807-9, 2013 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23612454
19.
Circulating tumor DNA detection in hepatocellular carcinoma.
Ann Oncol
; 29(5): 1094-1096, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29635453
20.
Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer.
Ann Oncol
; 24(5): 1231-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23275633